disclosure statement - cme conferences & continuing medical education
TRANSCRIPT
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
Papulosquamous Disorders
Richard P. Usatine, MD, FAAFPProfessor, Family and Community Medicine
Professor, Dermatology and Cutaneous SurgeryMedical Director, Skin Clinic
University of Texas Health Science Center, San Antonio
Disclosure Statement:• Co-President, Usatine Media
– medical app development company• Author, medical books
– Dermatologic and Cosmetic Procedures in Office Practice. Elsevier, Inc., Philadelphia. 2012.
– The Color Atlas of Family Medicine. McGraw-Hill, New York, 2009
• Off- label use:– Cyclosporine, Tacrolimus
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
Objectives
1. Identify the different types of papulosquamous disorders along with their distinguishing features.2. Collect clues for the clinical diagnosis of psoriasis and other papulosquamous disorders.3. Distinguish the different types of psoriasis.4. Compare treatment options for psoriasis.
Papulosquamous Disorders
• IN order of prevalence:
• Seborrhea• Psoriasis• Pityriasis rosea• Lichen planus
• Presentation will be in reverse order
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
Patient presentation
• A 38-year-old Hispanic woman presents with a rash on her forearms wrists ankle and back. She states the rash is mildly itchy and she does not like the way it looks.
All unlabeled photos are courtesy of Richard P. Usatine, MD
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
Koebner phenomenon
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
5 Ps of Lichen Planus
• Planar• Purple• Polygonal• Pruritic• Papule
Wickham’s lines
• Wickham’s striae (lacy, reticular white lines)
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
Skin Variants
• Hypertrophic• Follicular – scale on scalp, may lead
to cicatricial alopecia (lichen planopilaris)
• Vesicular or bullous• Actinic - typical lesions in sun-
exposed areas• Atrophic• Ulcerative
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
(Courtesy of Dan Stulberg, MD)
Skin Treatment
• May resolve in 8 – 18 months• Topical steroids (mid to high
potency)• Intralesional triamcinolone (3
mg/ml) may repeat every 3 to 4 weeks
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
Systemic Treatment
• For most severe and symptomatic cases.
• Three-week tapered course of oral prednisone (60 mg/d starting dose)
• Systemic retinoids - acitretin (Soriatane) 25 mg/day
• Mycophenolate mofetil • Cyclosporine (5 mg/kg/d)
Courtesy ofEJ Mayeaux, MDAnd the Color Atlas
CASE16 yo boy with a rash and mild itching
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
Pityriasis roseaRecognize and reassure
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
Pityriasis Rosea
• Human herpesvirus 6 (HHV-6) and HHV-7 may play a role in pathogenesis
• Comparison between the efficacy of high dose acyclovir and erythromycin for pityriasis rosea.– Indian J Dermatol. 2010 Jul-
Sep;55(3):246-8
Psoriasis Risk factors
• Family history• Obesity• Smoking• Heavy alcohol use
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
Age
• Plaque psoriasis first appears during 2 peak age ranges:
• 16-22 years of age• 57-60 years of age
9 categories of Psoriasis
1. Plaque (80%-90% of patients with psoriasis)2. Scalp psoriasis3. Guttate psoriasis4. Inverse psoriasis5. Palmar-plantar psoriasis. 6. Erythrodermic psoriasis.7. Pustular psoriasis—localized and generalized.8. Nail psoriasis. 9. Psoriatic arthritis
• AAD consensus statement on psoriasis therapies. JAAD. 2003;49:897-899.
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
Scalp psoriasis
• Seen at the hairline• Around ears
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
Guttate psoriasis
• small round plaques that resemble water drops (guttate means like a water drop)
• typical distribution: the trunk and extremities but may include the face and neck
• classically described as occurring after strep pharyngitis or another bacterial infection
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
Guttate psoriasis
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
Inverse psoriasis• found in the intertriginous areas of the axilla,
groin, inframammary folds, and intergluteal fold. It can also be seen below the pannus or within adipose folds in obese individuals.
• The name inverse refers to the fact that the distribution is not on extensor surfaces but in areas of body folds.
• Morphologically the lesions have little to no visible scale
• Color is generally pink to red but can be hyperpigmented in dark-skinned individuals
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
Palmar plantar psoriasis
• psoriasis occurs on the plantar aspects of the hands and feet (palms and soles).
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
(Courtesy of Jeffrey Meffert, MD)
Erythrodermic psoriasis
• Erythrodermic psoriasis is generally widespread and erythematosus.
• Morphologically it can have plaques and erythema or the erythroderma can appears with the desquamation of pustular psoriasis
• Widespread distribution can impair the important functions of the skin and this can be a dermatologic urgency requiring hospitalization and IV fluids.
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
Erythrodermic psoriasis with exfoliation
Courtesy of Jack Resneck, Sr, MD
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
Pustular psoriasis• Localized and generalized types.• Generalized type, the skin initially becomes fiery
red and tender and the patient experiences constitutional signs and symptoms, such as headache, fever, chills, arthralgia, malaise, anorexia, and nausea.
• desquamation that occurs in the generalized form can impair the important functions of the skin predisposing to dehydration and sepsis. dermatologic emergency requiring hospitalization and IV fluids
• flexural and anogenital• Less often, facial lesions occur
(Courtesy of Jack Resneck, Sr., MD)
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
(Courtesy of Jeffrey Meffert, MD)
Pustular psoriasis
• Within hours, clusters of nonfollicular, superficial 2- to 3-mm pustules may appear in a generalized pattern.
• These pustules coalesce within 1 day to form lakes of pus that dry and desquamate in sheets
• leaving behind a smooth erythematous surface on which new crops of pustules may appear.
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
(Courtesy of Meng Lu, MS3)
Nails
• nail involvement in psoriasis can lead to pitting, onycholysis, subungual keratosis, splinter hemorrhages, oil spots and nail loss.
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
Psoriatic Arthritis
Courtesy of Ricardo Zuniga-Montes, MD
Dactylitis
Nails involved
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
Disabling psoriatic arthritis
Making the diagnosis
• KOH preparation first if suspect fungal infection is possible
• Punch biopsy or scoop shave if not typical (if want to investigate for mycosis fungoides)
• Nails – KOH, culture or clipping for PAS stain
• Always inquire about psoriatic arthritis
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
Look for clues away from rash
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
Psoriatic arthritis
• History- ask about:–Morning stiffness– Joint pain
• Physical exam ––Fingers – DIP joint swelling, tenderness–Dactylitis – fat swollen fingers–Axial spine involvement–Enthesopathy – Achilles tendonitis
• X-ray – joint erosions
Non-pharmacologicalManagement
• Encourage smoking cessation to all who smoke.
• Minimize alcohol use. • Recommend weight loss if needed.• Recommend stress management
techniques.
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
Psoriasis Treatment Level 1 – topical or local
(may be all that is needed)
• Emollients• Topical steroids • Topical vitamin D• Topical retinoids• Topical calcineurin inhibitors • Topical tar and tar shampoo• Keratolytic agents• Intralesional steroids• Phototherapy – narrow-band UVB
Level 2 – Systemic(for more severe cases and pts with
psoriatic arthritis)
• Oral therapy - methotrexate, oral retinoids (acitretin), Cyclosporine
• New biologics – injectables• If psoriatic arthritis – start with
methotrexate and consider biologics
• Refer or get help to learn to use oral and biologic therapy for your patients
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
Oral steroids
• DO NOT USE ORAL or SYSTEMIC STEROIDS for psoriasis
• Prednisone even when tapered can precipitate generalized pustular psoriasis
Ointments • Use topical corticosteroid ointments rather than
creams because they are usually more effective than creams for psoriasis.
• On the face and flexures only mild to moderately potent topical corticosteroids should be used.
• On the other body areas treatment results will only be achieved with potent to very potent ointments.
• EBM Guideline. Essential Evidence Plus. SOR A.
• www.infopoems.com/inforetriever/display_article.cfm?resource=G&article=288
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
EBM - potent topical steroids
• Clobetasol is an ultra high potency steroid that is generic and comes in many vehicles for use on the body and scalp.
• A meta-analysis of the studies with clobetasol demonstrated 68-89% of patients had clear improvement or complete healing. SOR A.
• German evidence-based guidelines for the treatment of Psoriasis vulgaris. Arch Dermatol Res. 2007;299:111-138.
Taclonex
o combines betamethasone and calcipotriene to be applied once dailyo $573 for 60 gram tube of ointmento Convenient but costly
o Calcipotriene (Dovonex)o<$200 for 60 gram of generic
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
Topical Steroid Treatment of Psoriasis
• most common treatment• strong ointments are most effective• risks - skin atrophy, telangiectasias,
suppression of HPA
• intralesional steroid (up to 5 mg/ml) - good for isolated patches
Tacrolimus ointment(off-label)
Clinical trials suggest that tacrolimus 0.1 % ointment twice a day produces a good response in a majority of patients with facial, genital and inverse psoriasis. SOR B.
• Martin EG, et al. Topical tacrolimus for the treatment of psoriasis on the face, genitalia, intertriginous areas and corporal plaques. J Drugs Dermatol. 2006;5: 334–336.
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
Phototherapy• Extensive and widespread disease • Psoriasis not responding to topical therapy.• Narrowband UVB is more effective than
broadband UVB and approaches PUVA (psoralen and UVA) in efficacy.
• 63–80% of patients will clear with a course of narrowband UVB (equivalent relapse rates compared with PUVA).
• An update and guidance on narrowband ultraviolet B phototherapy: a British Photodermatology Group Workshop Report. Br J Dermatol. 2004;151:283-297.
MethotrexateVery effective for psoriasis and psoriatic arthritis. SOR ANeed to get PPD and check LFTs firstStart with weekly dose of 7.5 mg/week and taper up (max 25 mg/week)Follow LFTs and CBC regularlyreliable contraceptive methods should be used during and for at least three months after therapy in both men and women inexpensive medication with an over 40-year track record, but with known potential for hepatotoxicity Consider liver biopsy based to assess liver damage based on guidelines
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
Biologics
TNF inhibitors:•Adalimumab Humira•Etanercept Enbrel•Infliximab Remicade
Blocks interleukin 12 and 23:•Ustekinumab Stelara
Either monoclonal antibodies or receptor-antibody fusion protein• $20,000 - $40,000 per year
Scalp psoriasis
• Generic fluocinonide solution daily to the scalp is effective and affordable.
• Mineral oil or agents containing peanut oil may be used to moisturize and remove scale.
• Shampoos with tar and/or salicylic acid can help to dissolve and wash away some of the scale.
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
Palmar-plantar psoriasis
• Mild disease - start with topical treatments as in plaque psoriasis.
• For moderate to severe cases, systemic therapy such as oral acitretin, MTX, or biologic may be needed.
Life threatening psoriasis
• Erythrodermic/generalized psoriasis• Pustular/generalized psoriasis
–Treatment considerations include: Hospitalization for dehydration and close monitoring,
–Start cyclosporine or methotrexate–Consult a local expert for these cases
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
Seborrhea
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
Seborrheic dermatitis
• is a common inflammatory skin disorder
• Found in sites dense with sebaceous glands that support growth of the lipophilic yeast Malassezia furfur
• Also called Pityrosporum ovale or orbiculare – same organism as in tinea versicolor
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
Seborrheic dermatitis
• Inflammation is probably related to the overgrowth of the Pityrosporum
• Treatment will be two-pronged to diminish yeast overgrowth and fight inflammation
• Some conditions predispose to SD–HIV–Parkinson’s
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
HIV and Seborrheic Dermatitis
• common HIV-related opportunistic event
• May be an initial marker of immunodeficiency
• Improves with anti-viral therapy
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
Parkinson's increases risk of Seborrhea
Seborrhea flare in a hospitalized patient
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
Seborrhea in the nasolabial fold
with hyperpigmentation
Lupus spares the nasolabial fold andSeborrhea does not
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
Two Prong Treatment of Seborrhea
• Treat inflammation – steroids– 1% HC cream or lotion on face– lotion preferred on hair covered area – Desonide cream or lotion on face– if severe on scalp - may use fluocinonide
(Lidex) or clobetasol solution – Fluocinonide solution is affordable in 60 ml
bottles – use once daily
• Treat fungus - Antifungals
Treatment
• Antifungals -–skin: Ketoconazole (Nizoral) or
ciclopirox (Loprox) cream or any OTC azole antifungal
– scalp: Ketoconazole shampoo, Selenium sulfide, Zinc pyrithione
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
Steroids on face
• Hydrocortisone to start• Desonide 0.05% lotion – studied
twice weekly for 3 weeks with 88% clearing
– Efficacy, cutaneous tolerance and cosmetic acceptability of desonide 0.05% lotion (Desowen) versus vehicle in the short-term treatment of facial atopic or seborrhoeic dermatitis. The Australasian journal of dermatology. 43(3):186-9, 2002 Aug.
EBM - Antifungals
• Washing the scalp with ketoconazole shampoo and using topical treatment with creams containing imidazole derivatives can cut down on fungal growth and help treat seborrhea. SOR B
• Finnish Medical Society Duodecim. Seborrhoeic dermatitis. In: EBM Guidelines. Evidence-Based Medicine [CD-ROM]. Helsinki, Finland: Duodecim Medical Publications Ltd.; 2004 Apr 23
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
Cradle cap
• Start with selenium based shampoo – burns the eyes less than zinc containing shampoos
• Daily hair washing• 1% hydrocortisone or 0.05%
desonide cream or lotion• Mineral oil for scale as needed
Conclusions for Seborrhea
• Seborrheic dermatitis is found where Pityrosporum grows
• Treat inflammation – topical steroids• Treat fungus – antifungals• Frequent hair washing with
medicated shampoos
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders
Conclusions for Psoriasis• Psoriasis can be a tough disease to diagnose and
treat.• First, don’t miss the diagnosis – pay attention to
the scalp, intertriginous areas and the nails.• Investigate for psoriatic arthritis.• Assess the type, severity, distribution, patient’s
resources and preferences to choose initial therapy
• Try new therapies when initial therapies fail.• Refer or get a consult on the tough cases.• Learn how to use methotrexate and/or the
biologics if you have the motivation to do so.
References• Foulkes AC, et al. What's new in psoriasis? An analysis of
guidelines and systematic reviews published in 2009-2010. ClinExp Dermatol 2011.
• Paul C, et al. Evidence-based recommendations on conventional systemic treatments in psoriasis: systematic review and expert opinion of a panel of dermatologists. J Eur Acad Dermatol Venereol 2011;25 Suppl 2:2-11.
• Bansback N, et al. Efficacy of systemic treatments for moderate to severe plaque psoriasis: systematic review and meta-analysis. Dermatology 2009;219:209-218.
• Mason AR, et al. Topical treatments for chronic plaque psoriasis. Cochrane Database Syst Rev 2009;CD005028.
• Menter A, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. J Am Acad Dermatol 2009;60:643-659.
2nd Annual Primary Care Fall Conference Tuesday, October 23, 2012
Richard Usatine, MDPapulosquamous Disorders